Unlocking the potential of engineered immune cell therapy for solid tumors

Albarran Fernandez, Victor; Urbano-Ispizua, Alvaro; Guedan Carrio, Sonia; Angelats, Laura; Delgado, Julio; Gros, Alena

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Albarran Fernandez, Victor
dc.contributor.author	Urbano-Ispizua, Alvaro
dc.contributor.author	Guedan Carrio, Sonia
dc.contributor.author	Angelats, Laura
dc.contributor.author	Delgado, Julio
dc.contributor.author	Gros, Alena
dc.date.accessioned	2025-04-01T08:49:51Z
dc.date.available	2025-04-01T08:49:51Z
dc.date.issued	2025-01-29
dc.identifier.citation	Albarrán-Fernández V, Angelats L, Delgado J, Gros A, Urbano-Ispizua Á, Guedan S, et al. Unlocking the potential of engineered immune cell therapy for solid tumors. Nat Commun. 2025 Jan 29;16:1144.
dc.identifier.issn	2041-1723
dc.identifier.uri	http://hdl.handle.net/11351/12860
dc.description	Immune cell therapy; Solid tumors
dc.description.abstract	Adoptive cell therapy has emerged as a promising approach for treating advanced solid malignancies. Genetic engineering techniques represent an exciting area of research for the development of cellular products with enhanced cytotoxicity, phenotype, and metabolism.
dc.language.iso	eng
dc.publisher	Nature Portfolio
dc.relation.ispartofseries	Nature Communications;16
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scientia
dc.subject	Càncer - Immunoteràpia
dc.subject	Teràpia cel·lular
dc.subject.mesh	Neoplasms
dc.subject.mesh	/therapy
dc.subject.mesh	Immunotherapy, Adoptive
dc.subject.mesh	Immunotherapy, Adoptive
dc.title	Unlocking the potential of engineered immune cell therapy for solid tumors
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1038/s41467-025-56527-0
dc.subject.decs	neoplasias
dc.subject.decs	/terapia
dc.subject.decs	inmunoterapia adoptiva
dc.subject.decs	inmunoterapia adoptiva
dc.relation.publishversion	https://doi.org/10.1038/s41467-025-56527-0
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Albarrán-Fernández V, Angelats L] Medical Oncology Department, Hospital Clínic, Barcelona, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. [Delgado J, Urbano-Ispizua Á] Oncoimmunotherapy Unit, Department of Hematology, Hospital Clínic, Barcelona, Spain. Department of Medicine, University of Barcelona, Barcelona, Spain. [Gros A] Tumor Immunology and Immunotherapy, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Gueda S] Cellular Immunotherapies for Cancer, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
dc.identifier.pmid	39880825
dc.identifier.wos	001410925600007
dc.rights.accessrights	info:eu-repo/semantics/openAccess